Filter
1676
Filtered Results: 1676
Text search:
registration
of
drugs
Featured
Recommendations
144
New Publications
558
Language
Document type
No document type
1151
Guidelines
189
Studies & Reports
170
Manuals
63
Strategic & Response Plan
61
Training Material
17
Situation Updates
10
Fact sheets
10
Resource Platforms
4
Brochures
1
Countries / Regions
India
162
Kenya
72
Sierra Leone
46
Uganda
45
Nigeria
44
Nepal
43
Ethiopia
41
South Africa
41
Ghana
40
Rwanda
38
Malawi
35
Tanzania
33
Liberia
32
Bangladesh
31
Western and Central Europe
31
Global
31
Myanmar / Burma
27
Zambia
24
Namibia
23
Africa
23
Ukraine
22
Botswana
19
Philippines
17
Eastern Europe
17
Latin America and the Carribbean
16
Zimbabwe
15
Syria
15
Cambodia
14
Indonesia
13
Lesotho
13
South Sudan
12
Asia
12
Mozambique
11
South–East Asia Region
11
Congo, Democratic Republic of
9
Senegal
6
Pakistan
6
Eswatini/ Swaziland
6
Colombia
6
Russia
6
Tajikistan
5
Haiti
4
Jordan
4
Lebanon
4
Sudan
4
Benin
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Albania
4
Cameroon
3
Iraq
3
Afghanistan
3
Germany
3
Brazil
3
North Macedonia
3
Sri Lanka
3
West and Central Africa
3
Venezuela
3
Moldova
3
Iran
3
Georgia
3
Burkina Faso
2
Saudi Arabia
2
Argentina
2
Greece
2
Libya
2
Angola
2
Chile
2
Middle East and North Africa
2
Bhutan
2
Palestine
2
Armenia
2
Laos
2
Turkmenistan
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Somalia
1
Egypt
1
Thailand
1
Gambia
1
China
1
Malaysia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Ecuador
1
Bolivia
1
Madagascar
1
Yemen
1
Paraguay
1
Fiji
1
Djibouti
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
878
Clinical Guidelines
129
Public Health
71
Women & Child Health
60
Key Resources
34
Pharmacy & Technologies
28
Capacity Building
22
Toolboxes
TB
170
HIV
165
Pharmacy
74
Mental Health
71
AMR
70
COVID-19
53
Conflict
42
NTDs
34
Caregiver
33
Refugee
25
NCDs
23
Disability
22
Rapid Response
15
Global Health Education
13
Ebola
10
Natural Hazards
10
Specific Hazards
8
Planetary Health
8
Polio
4
Health Financing Toolbox
4
Cholera
3
Zika
3
Social Ethics
3
South Sudan
2
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existin...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to ...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Manual for use in primary care.
There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural rele...
The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability ... DAAs has improved significantly, but access remains lim-
ited. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
Framework for implementation.
The END TB Strategy.
